Patent · US Active

Melanoma antigen peptide and uses thereof

US8604166B2 · kind B2 · utility

1Cited by

0References

5Claims

0Family size

Assignees

INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR
UNIVERSITE DE NANTES · FR
CHU NANTES · FR

Inventors

Nathalie Labarriere · Nantes, FR
Agnes Moreau-Aubry · Nantes, FR
Yann Godet · Nantes, FR

Key dates

Filing date	Sep 2, 2009
Grant date	Dec 10, 2013
Priority date	—
Expiry date	Mar 1, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2239/57
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel melanoma antigen peptides and specific T lymphocytes directed to said peptides and the use thereof for treating melanoma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.